Skip to main content

TU · Telus Corp

Track TU — free
Market Cap
$17.60B
Shares
1.59B
Volume · Nov 20 19M Avg daily vol (3M) 8.05M

Price & Indicators

 

Key stats

Close
$11.07
Fri 20 Nov
Open
$11.00
Fri 20 Nov
Average volume, 30 days
9.9M
shares a session
Short interest
48.9M
3.1% of shares · 8.3 days to cover
Day range
$10.99$11.27
Open $11.00 Close $11.07
52-week closing range
$7.72$14.31
Close $11.07 22.6% under the high
Short volume, last session
60%
Last earnings
Nov 6, 2026
Price history
Jan 2020 to Nov 2026

Up next

Feb 11, 2027 Est · unconfirmed · in 12 wks

Latest documents

2026
Nov 16
Current report 6-K
Québecor proposal draws regulatory and valuation concerns

TELUS confirmed Québecor’s unsolicited acquisition proposal, which its Special Committee of independent directors is reviewing. The committee identified regulatory, execution, governance and valuation risks; no decision has been made on pursuing a transaction or maintaining the status quo.

3 source passages
TELUS confirms receipt of unsolicited proposal from Québecor, continues review of strategic alternatives The Special Committee's review has identified significant regulatory and execution risks associated with the proposed Québecor transaction The Special Committee is continuing its evaluation of the Québecor proposal and the other strategic alternatives available to the company, and no decision has been made at this time whether to pursue a transaction or maintain the status quo. Open the document at this passage
Nov 6
Earnings call
$900 million annualized cash savings program targets exit in 2028

Telus announced a program targeting $900 million in annualized cash savings exiting 2028, with up to 80% from telecom. Consolidated service revenue was $4.5 billion, lower by 1% year-over-year, and an $800 million non-cash goodwill impairment was recorded for TELUS Health.

4 source passages
Today, we are announcing a program that targets $900 million in annualized cash savings, exiting 2028 Up to 80% of these run rate savings are expected to come from telecom, with the balance coming from the global platform businesses. Consolidated service revenue of $4.5 billion was lower by 1% year-over-year. we recorded a non-cash goodwill impairment of $800 million for our TELUS Health business Open the document at this passage
Nov 6
Current report 6-K
Marc Allera and Bill Thomas appointed to board

TELUS Corporation appointed Marc Allera and Bill Thomas to its board, effective January 1, 2027, adding telecommunications, financial reporting, risk management and audit oversight expertise.

Source passage
TELUS Corporation (TSX: T, NYSE: TU) today announced the TELUS Board of Directors (the Board) has approved the appointments of Marc Allera and Bill Thomas to its Board, effective January 1, 2027. Open the document at this passage
Nov 6
Current report 6-K
Quarterly dividend of $0.1875 Canadian per share declared

TELUS Corporation's Board declared a quarterly dividend of $0.1875 Canadian per share, payable January 4, 2027 to shareholders of record December 11, 2026.

2 source passages
TELUS Corporation NOTICE IS HEREBY GIVEN that the Board of Directors has declared a quarterly dividend of $0.1875 Canadian per share on the issued and outstanding Common shares payable on January 4, 2027 to shareholders of record at the close of business on December 11, 2026. Open the document at this passage
Nov 6
Current report 6-K
Targets $900 million savings despite $660 million net loss

TELUS reported a $660 million net loss for third quarter 2026, including an $800 million non-cash goodwill impairment, and launched an efficiency program targeting approximately $900 million in annualized cash savings exiting 2028.

Read from the first part of this long document
3 source passages
TELUS Corporation (TSX: T, NYSE: TU) today released its unaudited results for the third quarter ended September 30, 2026. In support of Transformation Strategy, announcing an efficiency program targeting annualized cash savings of approximately $900 million exiting 2028 to be delivered via operational cost and margin improvement, and capital expenditure efficiencies. Net loss of $660 million driven by a pre-tax, non-cash goodwill impairment of $800 million, reflecting a reduction in the recoverable amount of the TELUS Health cash-generating unit due to updated growth expectations, broader market conditions and valuation update within the health portfolio as a result of the active divestiture process. Open the document at this passage
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$14.70B
Trailing 12 months
Net income (TTM)
−$665.19M
Trailing 12 months
Revenue growth YoY
-3.0%
Year over year
Operating margin
2.0%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
9.3%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+3.0%
Year over year · more shares
Price change (1Y)
-17.2%
Trailing year
Short interest
3.1%
Latest settlement · 8.3 days to cover
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Weak Sentiment Neutral Fundamentals Limited Quant / Vol High
Market backdrop VIX 35.9 · fear Equity put/call 0.62
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +1%
above
Price vs 50-day avg +27%
above
RSI (14) 75
overbought
MACD trend Positive
52-week position 51%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return +25%
trailing
6-month return −12%
trailing
YTD return −16%
this year
Relative strength −3%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $9 › 200d $11 — 200d above 50d
Institutional flow Distributing
-3% holders QoQ · +36 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
3.08% of shares out · ▼ -8.1% MoM · 8.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
283 holders — near 3-yr low, contrarian setup
Squeeze score 87
high risk · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
High
Volatility 32%
annualized · 1-yr
Max drawdown −46%
past year
ATR 3.6%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Nov 6, 2026
through exiting 2028
Net cash savings $900M
in 27 versus 28
Investments related to the savings program (primarily CapEx) $150M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
1 · 3 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+1% Bullish
Price vs 50-day avg
+27% Bullish
RSI (14)
75 Bearish
MACD trend
Positive Bullish
52-week position
51% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $9 › 200d $11 — 200d above 50d
Institutional flow Distributing
-3% holders QoQ · +36 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
3.08% of shares out · ▼ -8.1% MoM · 8.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
283 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $8 Now $11 · 51% Range high $14
vs 200-day avg +1% vs 50-day avg +27%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Telecom Services — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
TU
Telus Corp
this stock
$17.60B -15.9% — — 3.1%
VZ
Verizon Communications Inc
$192.64B +14.1% +2.5% 11.8 2.0%
TMUS
T-Mobile US, Inc.
$175.42B -18.4% +8.3% 16.0 1.5%
T
At&T Inc.
$150.29B -10.2% +2.7% 12.1 2.0%
DTEGY
Deutsche Telekom AG
$137.07B -12.4% — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
283
% held
45.7%
Net QoQ
+44.3M sh
Top holder
ROYAL BANK OF CANADA
Held Float
View
Held by Funds
Fund positions
160
View
Short & Settlement
Short Interest Falling
Shares short
48.9M
Days to cover
8.3d
Change
-4.3M sh
View
Short Volume
Short vol %
60%
As of
Nov 20, 2026
Short Total
View
Fails to Deliver
FTD shares
205
Value
$1.8K
As of
Oct 30, 2026
View
Off-Exchange
Off-exchange %
38.2%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
Thomas R Carper
Amount
$1.0K–$15.0K
Traded
Jan 11, 2023
View
Filings
SEC Filings
Latest
6-K
Filed
Nov 16, 2026
This year
26

TELUS confirmed Québecor’s unsolicited acquisition proposal, which its Special Committee of independent directors is reviewing. The committee identified regulatory, execution, governance and valuation risks; no decision has been made on pursuing a transaction or maintaining the status quo.

View
Earnings & Events
Webcasts
Last webcast
Nov 6, 2026
View

Performance

5D 20D 120D MTD YTD
TU +29.8% +25.4% -11.9% +24.8% -16.0%
SPY -8.6% -9.2% -9.2% -8.7% +1.2%
vs SPY +38.3% +34.6% -2.7% +33.5% -17.1%
Key facts CIK 868675 CUSIP 87971M103 13F (30d) 286 filings 249 filers Visit website